Valesthesie
ActiveSummary
Valesthesie has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €110,183 and a net result of €214,073. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 73% of 17112 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100▲+62
Growth78▲+20
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €10,000 at 30 days acceptable
Liquidity ample (current ratio 6.15 against 1.04 in 2024; short-term debt: 16.1% and cash: 40.8% of total assets), and 16.7% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
83.3%
Return on assets
161.8%
Age of the figures
9 mo
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
202122232425
2020 to 2025 · latest year €110,183
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
16 d early
2024
28 d late
2023
28 d late
2022
31 d late
2021
3 d early
2020
4 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 11 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 28 August (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€110,183▲ 453%
2024 · €19,933
Total assets
€132,336▼ 12.2%
2024 · €150,784
Net result
€214,073▼ 30.5%
2024 · €308,105
Working capital
€109,857▲ 1,785%
2024 · €5,827
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€243,300▲ 248%€159,171▼ 34.6%€330,500▲ 108%€417,814▲ 26.4%€286,626▼ 31.4%
Net result€187,132above the sector's middle half▲ 240%€123,727above the sector's middle half▼ 33.9%€250,111above the sector's middle half▲ 102%€308,105above the sector's middle half▲ 23.2%€214,073above the sector's middle half▼ 30.5%
Equity€245,247within the sector's middle half▲ 322%€368,974within the sector's middle half▲ 50.4%€17,123below the sector's middle half▼ 95.4%€19,933below the sector's middle half▲ 16.4%€110,183within the sector's middle half▲ 453%
Total assets€305,120within the sector's middle half▲ 309%€465,753within the sector's middle half▲ 52.6%€264,844within the sector's middle half▼ 43.1%€150,784within the sector's middle half▼ 43.1%€132,336within the sector's middle half▼ 12.2%
Debt€59,873▲ 264%€96,779▲ 61.6%€247,721▲ 156%€130,850▼ 47.2%€22,153▼ 83.1%
Working capital€229,672within the sector's middle half▲ 384%€357,735above the sector's middle half▲ 55.8%€10,804below the sector's middle half▼ 97.0%€5,827below the sector's middle half▼ 46.1%€109,857within the sector's middle half▲ 1,785%
Solvency80.4%within the sector's middle half▲ 2.4pp79.2%within the sector's middle half▼ 1.2pp6.5%below the sector's middle half▼ 72.8pp13.2%below the sector's middle half▲ 6.8pp83.3%within the sector's middle half▲ 70.0pp
Current ratio4.86within the sector's middle half▲ 0.974.71within the sector's middle half▼ 0.141.04below the sector's middle half▼ 3.671.04below the sector's middle half=6.15within the sector's middle half▲ 5.10
Return on assets (ROA)61.3%above the sector's middle half▼ 12.6pp26.6%within the sector's middle half▼ 34.8pp94.4%above the sector's middle half▲ 67.9pp204.3%above the sector's middle half▲ 109.9pp161.8%above the sector's middle half▼ 42.6pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 31% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €132,336
Fixed assets
€1,128 ▼ 92.2%
Current assets
€131,208 ▼ 3.8%
Equity and liabilities €132,336
Equity
€110,183 ▲ 453%
Debt
€22,153 ▼ 83.1%
Debt's share of the balance-sheet total falls from 86.8% to 16.7%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€293,387▼
2024 · €422,845
Cash flow
€220,834▼
2024 · €313,135
Debt to equity
0.20▼
2024 · 6.56
ROE
194.3%
Interest coverage
391.50▼
2024 · 784.67
Debt ≤ 1 year
€21,351▼
2024 · €130,522
Income taxes
€72,153▼
2024 · €109,350
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.6%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €7,599 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €3,157 | €4,813 | €4,813 | €5,030 | €6,761 | ▲ 34.4% |
| Other operating charges640/8 | €301 | €804 | €825 | €976 | €888 | ▼ 9.0% |
| Gross operating margin9900 | €246,759 | €164,788 | €336,138 | €423,821 | €294,275 | ▼ 30.6% |
| Operating profit (loss)9901 | €243,300 | €159,171 | €330,500 | €417,814 | €286,626 | ▼ 31.4% |
| Financial income75/76B | €0 | €15 | €99 | €180 | €350 | ▲ 94.5% |
| Recurring financial income75 | €0 | €15 | €99 | €180 | €350 | ▲ 94.5% |
| Financial charges65/66B | €80 | €111 | €216 | €539 | €749 | ▲ 39.1% |
| Recurring financial charges65 | €80 | €111 | €216 | €539 | €749 | ▲ 39.1% |
| Profit (loss) for the period before taxes9903 | €243,221 | €159,075 | €330,383 | €417,455 | €286,226 | ▼ 31.4% |
| Income taxes67/77 | €56,089 | €35,348 | €80,272 | €109,350 | €72,153 | ▼ 34.0% |
| Profit (loss) for the period9904 | €187,132 | €123,727 | €250,111 | €308,105 | €214,073 | ▼ 30.5% |
| Profit (loss) for the period to be appropriated9905 | €187,132 | €123,727 | €250,111 | €308,105 | €214,073 | ▼ 30.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €305,120 | €465,753 | €264,844 | €150,784 | €132,336 | ▼ 12.2% |
| Fixed assets21/28 | €15,878 | €11,627 | €6,815 | €14,434 | €1,128 | ▼ 92.2% |
| Tangible fixed assets22/27 | €15,878 | €11,627 | €6,815 | €14,434 | €1,128 | ▼ 92.2% |
| Plant, machinery and equipment23 | €11,666 | €8,307 | €4,386 | €1,852 | €483 | ▼ 73.9% |
| Furniture and vehicles24 | €4,212 | €3,320 | €2,429 | €12,582 | €645 | ▼ 94.9% |
| Current assets29/58 | €289,243 | €454,126 | €258,029 | €136,350 | €131,208 | ▼ 3.8% |
| Amounts receivable within one year40/41 | €1,812 | €9,467 | €2,045 | €7,337 | €10,178 | ▲ 38.7% |
| Trade receivables40 | €1,250 | €9,467 | €2,045 | €6,204 | €2,228 | ▼ 64.1% |
| Other amounts receivable41 | €562 | - | - | €1,134 | €7,950 | ▲ 601% |
| Cash at bank and in hand54/58 | €281,976 | €443,028 | €248,493 | €121,890 | €53,981 | ▼ 55.7% |
| Deferred charges and accrued income490/1 | €5,455 | €1,631 | €7,491 | €7,122 | €67,049 | ▲ 841% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €305,120 | €465,753 | €264,844 | €150,784 | €132,336 | ▼ 12.2% |
| Equity10/15 | €245,247 | €368,974 | €17,123 | €19,933 | €110,183 | ▲ 453% |
| Contributions10/11 | €3,000 | €3,000 | €3,000 | €3,000 | €3,000 | = |
| Reserves13 | €242,247 | €365,974 | €14,123 | €16,933 | €107,183 | ▲ 533% |
| Distributable reserves133 | €242,247 | €365,974 | €14,123 | €16,933 | €107,183 | ▲ 533% |
| Amounts payable17/49 | €59,873 | €96,779 | €247,721 | €130,850 | €22,153 | ▼ 83.1% |
| Amounts payable within one year42/48 | €59,570 | €96,392 | €247,225 | €130,522 | €21,351 | ▼ 83.6% |
| Trade debts44 | €1,580 | €2,703 | €1,616 | €588 | €535 | ▼ 9.0% |
| Suppliers440/4 | €1,580 | €2,703 | €1,616 | €588 | €535 | ▼ 9.0% |
| Taxes, remuneration and social security45 | €56,089 | €91,490 | €61,772 | €54,296 | €14,894 | ▼ 72.6% |
| Taxes450/3 | €56,089 | €91,490 | €61,772 | €54,296 | €5,594 | ▼ 89.7% |
| Remuneration and social security454/9 | - | - | - | - | €9,300 | - |
| Other amounts payable47/48 | €1,901 | €2,198 | €183,837 | €75,638 | €5,922 | ▼ 92.2% |
| Accrued charges and deferred income492/3 | €303 | €388 | €496 | €328 | €803 | ▲ 145% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €187,132 | €123,727 | €250,111 | €308,105 | €214,073 | ▼ 30.5% |
| + Depreciation and write-downs630 | €3,157 | €4,813 | €4,813 | €5,030 | €6,761 | ▲ 34.4% |
| Operating cash flow (approximation) | €190,289 | €128,540 | €254,923 | €313,135 | €220,834 | ▼ 29.5% |
| Investment in fixed assets (approximation) | - | -€562 | €0 | -€12,649 | €6,545 | ▲ 152% |
| Change in cash | - | €161,052 | -€194,535 | -€126,603 | -€67,909 | ▲ 46.4% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
15-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Liquidity times 6current ratio 6.15
Current ratio from 1.04 to 6.15; short-term debt falls from €130,522 to €21,351.
31-12
Financial
Equity above €100,000Eq €110,183 ▲453%
6 profitable years in a row build equity to €110,183.
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
31-12
Financial
Highest result since 2020net €308,105 ▲23.2%
Operating result €417,814, net result €308,105, both a record.
28-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 28 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Equity above €200,000Eq €245,247 ▲322%
2 profitable years in a row build equity to €245,247.
27-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 2 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2019
Ground area
150 m²
Building footprint
109 m²
Volume, LiDAR
1,107 m³
Parcel 11810K1522/00D004, Flanders · tallest building 17.0 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Valesthesie
since 20192.296.377.901
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11810K1522/00D004 | Flanders | 150 m² | 1 · 109 m² | 17.0 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. CATHY DIERCKXSENS
BE 0479.004.014
Brussel · Eq €110,108
MACQS
BE 0805.857.390
Jodoigne · Eq €110,096
HUISARTSENPRAKTIJK DR. ROGER ARTOIS
BE 0831.565.657
Zaventem · Eq €110,294
DOKTER TOM MOERMAN
BE 0753.841.339
Gent · Eq €110,061
Dokter Lucas LUYCKX Orthopedie - Traumatologie
BE 0733.705.525
Kampenhout · Eq €110,333
Of 16,625 companies in this sector we hold annual accounts for 7,989. 6,460 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded03-12-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
63920Other information service activities
E-invoicing
Reachable via Peppol
Peppol ID
0208:0738689345
Also
9925:BE0738689345
Registered
11-09-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.